Article Text

Download PDFPDF
When and Who Should Perform Epithelial Ovarian Cancer Surgery?
  1. Cecilia Escayola, MD*,
  2. Juan Jose Torrent, MD*,
  3. Gwenaël Ferron, PhD,
  4. François Quenet, MD and
  5. Denis Querleu, PhD§
  1. * Department of Gynecologic Oncology, Hospital Pilar, Barcelona, Spain; Departments of
  2. Gynecologic Oncology, and
  3. General Surgery, CLCC Institut Claudius Regaud, Toulouse; and
  4. § Department of Gynecologic Oncology, Institut Bergonie’, Bordeaux, France.
  1. Address correspondence and reprint requests to Cecilia Escayola, MD, Hospital Pilar, Balmes 271, 08006, Barcelona, Spain. E-mail: ceciliaescayola{at}


Abstract Epithelial ovarian cancer is the most common cause of death due to gynecologic malignancies. Most patients will be diagnosed at an advanced stage, and despite progress in both surgical procedures and novel targeted therapies, the overall survival of these patients remains very low. Among prognostic factors, the International Federation of Gynecology and Obstetrics stage and residual tumor after debulking surgery are the most widely reported. The current review aims to highlight the disparities in the treatment of patients with ovarian cancer and the need for postgraduate training programs in order to accredit gynecologic oncologists. Despite an increase over the centralization of these patients, many are still not receiving specialized surgery.

  • Ovarian cancer surgery
  • Centralization of patients
  • Training programs

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.